Luke M. Reilly


Luke M. Reilly


Philadelphia | Cira Centre, 2929 Arch Street, Philadelphia, PA, United States of America 19104-2808
+1 215 994 2194 | +1 215 994 2222


Luke M. Reilly represents clients in a variety of intellectual property and commercial matters, focusing primarily on litigating patent and trade secret claims. His experience spans technology areas, ranging from wireless cellular systems to pharmaceutical compositions to printing technology. He has experience in all phases of litigation, including factual investigation, drafting complaints and answers, preparing motion and declarations, discovery, Markman briefing, working with experts and expert testimony, taking fact and expert depositions and pre- and post-trial briefing.

Mr. Reilly also maintains an active pro bono practice, working with Philadelphia VIP to assist tenants involved in landlord-tenant disputes in Philadelphia Municipal Court.

  • Columbia Law School, J.D., 2017
  • University of Pennsylvania, B.A., 2011
  • Pennsylvania
  • Supreme Court of the United States
  • United States District Court for the Eastern District of Pennsylvania
  • United States Court of Appeals for the Federal Circuit
  • Trinity Graphic, USA, Inc. v. Tervis Tumbler Co. et al. (M.D. Fla.) Represent SGS International as defendant in trade secret litigation relating to printing technologies for tumbler inserts. Case settled with Plaintiff dropping all claims against our client.
  • Intellectual Ventures I LLC v. T-Mobile USA, Inc. et al. (E.D. Tex.).  Represented Intellectual Ventures in patent infringement action involving wireless LTE technology. Following trial, the jury found all of our client’s patents valid and infringed.
  • Jazz Pharmaceuticals, Inc. v. Synchrony Group, LLC et al. (E.D. Pa.). Representing Jazz Pharmaceuticals in trade secret dispute regarding industry knowledge provided confidentially to marketing agent. Case is ongoing.
  • Par Pharmaceutical, Inc. et al. v. Eagle Pharmaceuticals Inc. (D. Del.). Representing Par Pharmaceutical, Inc. in Hatch-Waxman case filed against multiple generic companies involving Par’s VASOSTRICT® product. Case is ongoing.